- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Market Overview
The Biosimilar Monoclonal Antibodies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Biosimilar Monoclonal Antibodies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 26.5%% in the forecast period of 2020 to 2025 and will expected to reach USD 12060 million by 2025, from USD 4706.7 million in 2019.
Market segmentation
Biosimilar Monoclonal Antibodies market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biosimilar Monoclonal Antibodies market has been segmented into
Infliximab
Rituximab
Trastuzumab
Adalimumab
Other
By Application, Biosimilar Monoclonal Antibodies has been segmented into:
Oncology
Autoimmune Disease
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biosimilar Monoclonal Antibodies market presented in the report. This section sheds light on the sales growth of different regional and country-level Biosimilar Monoclonal Antibodies markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biosimilar Monoclonal Antibodies market.
The report offers in-depth assessment of the growth and other aspects of the Biosimilar Monoclonal Antibodies market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Biosimilar Monoclonal Antibodies Market Share Analysis
Biosimilar Monoclonal Antibodies competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biosimilar Monoclonal Antibodies sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biosimilar Monoclonal Antibodies sales, revenue and market share for each player covered in this report.
The major players covered in Biosimilar Monoclonal Antibodies are:
Celltrion
Hisun Pharma
Novartis (Sandoz)
Pfizer (Hospira)
Cadila Healthcare
3SBIO
Celgen Biopharma
Dr Reddy’s
Torrent Pharmaceuticals
Among other players domestic and global, Biosimilar Monoclonal Antibodies market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biosimilar Monoclonal Antibodies product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biosimilar Monoclonal Antibodies, with price, sales, revenue and global market share of Biosimilar Monoclonal Antibodies in 2018 and 2019.
Chapter 3, the Biosimilar Monoclonal Antibodies competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biosimilar Monoclonal Antibodies breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Biosimilar Monoclonal Antibodies market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Biosimilar Monoclonal Antibodies sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Biosimilar Monoclonal Antibodies Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biosimilar Monoclonal Antibodies Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Infliximab
1.2.3 Rituximab
1.2.4 Trastuzumab
1.2.5 Adalimumab
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Biosimilar Monoclonal Antibodies Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Autoimmune Disease
1.3.4 Other
1.4 Overview of Global Biosimilar Monoclonal Antibodies Market
1.4.1 Global Biosimilar Monoclonal Antibodies Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Celltrion
2.1.1 Celltrion Details
2.1.2 Celltrion Major Business
2.1.3 Celltrion SWOT Analysis
2.1.4 Celltrion Product and Services
2.1.5 Celltrion Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Hisun Pharma
2.2.1 Hisun Pharma Details
2.2.2 Hisun Pharma Major Business
2.2.3 Hisun Pharma SWOT Analysis
2.2.4 Hisun Pharma Product and Services
2.2.5 Hisun Pharma Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis (Sandoz)
2.3.1 Novartis (Sandoz) Details
2.3.2 Novartis (Sandoz) Major Business
2.3.3 Novartis (Sandoz) SWOT Analysis
2.3.4 Novartis (Sandoz) Product and Services
2.3.5 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer (Hospira)
2.4.1 Pfizer (Hospira) Details
2.4.2 Pfizer (Hospira) Major Business
2.4.3 Pfizer (Hospira) SWOT Analysis
2.4.4 Pfizer (Hospira) Product and Services
2.4.5 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Cadila Healthcare
2.5.1 Cadila Healthcare Details
2.5.2 Cadila Healthcare Major Business
2.5.3 Cadila Healthcare SWOT Analysis
2.5.4 Cadila Healthcare Product and Services
2.5.5 Cadila Healthcare Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 3SBIO
2.6.1 3SBIO Details
2.6.2 3SBIO Major Business
2.6.3 3SBIO Product and Services
2.6.4 3SBIO Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Celgen Biopharma
2.7.1 Celgen Biopharma Details
2.7.2 Celgen Biopharma Major Business
2.7.3 Celgen Biopharma Product and Services
2.7.4 Celgen Biopharma Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Dr Reddy’s
2.8.1 Dr Reddy’s Details
2.8.2 Dr Reddy’s Major Business
2.8.3 Dr Reddy’s Product and Services
2.8.4 Dr Reddy’s Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Torrent Pharmaceuticals
2.9.1 Torrent Pharmaceuticals Details
2.9.2 Torrent Pharmaceuticals Major Business
2.9.3 Torrent Pharmaceuticals Product and Services
2.9.4 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Biosimilar Monoclonal Antibodies Manufacturer Market Share in 2019
3.3.2 Top 6 Biosimilar Monoclonal Antibodies Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Regions
4.1.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Regions (2015-2020)
4.1.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Regions (2015-2020)
4.2 North America Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
4.3 Europe Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
4.5 South America Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Country
5.1.1 North America Biosimilar Monoclonal Antibodies Sales and Market Share by Country (2015-2020)
5.1.2 North America Biosimilar Monoclonal Antibodies Revenue and Market Share by Country (2015-2020)
5.2 United States Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
5.3 Canada Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
5.4 Mexico Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Country
6.1.1 Europe Biosimilar Monoclonal Antibodies Sales and Market Share by Country (2015-2020)
6.1.2 Europe Biosimilar Monoclonal Antibodies Revenue and Market Share by Country (2015-2020)
6.2 Germany Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
6.3 UK Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
6.4 France Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
6.5 Russia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
6.6 Italy Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Biosimilar Monoclonal Antibodies Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Biosimilar Monoclonal Antibodies Revenue and Market Share by Regions (2015-2020)
7.2 China Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
7.3 Japan Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
7.4 Korea Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
7.5 India Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
7.7 Australia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Country
8.1.1 South America Biosimilar Monoclonal Antibodies Sales and Market Share by Country (2015-2020)
8.1.2 South America Biosimilar Monoclonal Antibodies Revenue and Market Share by Country (2015-2020)
8.2 Brazil Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
8.3 Argentina Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Biosimilar Monoclonal Antibodies Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Biosimilar Monoclonal Antibodies Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
9.3 Turkey Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
9.4 Egypt Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
9.5 South Africa Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Type (2015-2020)
10.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2015-2020)
10.3 Global Biosimilar Monoclonal Antibodies Price by Type (2015-2020)
11 Global Biosimilar Monoclonal Antibodies Market Segment by Application
11.1 Global Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2020)
11.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Application (2015-2020)
11.3 Global Biosimilar Monoclonal Antibodies Price by Application (2015-2020)
12 Market Forecast
12.1 Global Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate (2021-2025)
12.2 Biosimilar Monoclonal Antibodies Market Forecast by Regions (2021-2025)
12.2.1 North America Biosimilar Monoclonal Antibodies Market Forecast (2021-2025)
12.2.2 Europe Biosimilar Monoclonal Antibodies Market Forecast (2021-2025)
12.2.3 Asia-Pacific Biosimilar Monoclonal Antibodies Market Forecast (2021-2025)
12.2.4 South America Biosimilar Monoclonal Antibodies Market Forecast (2021-2025)
12.2.5 Middle East & Africa Biosimilar Monoclonal Antibodies Market Forecast (2021-2025)
12.3 Biosimilar Monoclonal Antibodies Market Forecast by Type (2021-2025)
12.3.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Type (2021-2025)
12.3.2 Global Biosimilar Monoclonal Antibodies Market Share Forecast by Type (2021-2025)
12.4 Biosimilar Monoclonal Antibodies Market Forecast by Application (2021-2025)
12.4.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Application (2021-2025)
12.4.2 Global Biosimilar Monoclonal Antibodies Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
List of Tables
Table 1. Global Biosimilar Monoclonal Antibodies Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biosimilar Monoclonal Antibodies by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biosimilar Monoclonal Antibodies Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Biosimilar Monoclonal Antibodies Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Celltrion Basic Information, Manufacturing Base and Competitors
Table 9. Celltrion Biosimilar Monoclonal Antibodies Major Business
Table 10. Celltrion Biosimilar Monoclonal Antibodies Total Revenue (USD Million) (2018-2019)
Table 11. Celltrion SWOT Analysis
Table 12. Celltrion Biosimilar Monoclonal Antibodies Product and Services
Table 13. Celltrion Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Hisun Pharma Basic Information, Manufacturing Base and Competitors
Table 15. Hisun Pharma Biosimilar Monoclonal Antibodies Major Business
Table 16. Hisun Pharma Biosimilar Monoclonal Antibodies Total Revenue (USD Million) (2018-2019)
Table 17. Hisun Pharma SWOT Analysis
Table 18. Hisun Pharma Biosimilar Monoclonal Antibodies Product and Services
Table 19. Hisun Pharma Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Novartis (Sandoz) Basic Information, Manufacturing Base and Competitors
Table 21. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Major Business
Table 22. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Total Revenue (USD Million) (2018-2019)
Table 23. Novartis (Sandoz) SWOT Analysis
Table 24. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Product and Services
Table 25. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Pfizer (Hospira) Basic Information, Manufacturing Base and Competitors
Table 27. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Major Business
Table 28. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Total Revenue (USD Million) (2018-2019)
Table 29. Pfizer (Hospira) SWOT Analysis
Table 30. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Product and Services
Table 31. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Cadila Healthcare Basic Information, Manufacturing Base and Competitors
Table 33. Cadila Healthcare Biosimilar Monoclonal Antibodies Major Business
Table 34. Cadila Healthcare Biosimilar Monoclonal Antibodies Total Revenue (USD Million) (2018-2019)
Table 35. Cadila Healthcare SWOT Analysis
Table 36. Cadila Healthcare Biosimilar Monoclonal Antibodies Product and Services
Table 37. Cadila Healthcare Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. 3SBIO Basic Information, Manufacturing Base and Competitors
Table 39. 3SBIO Biosimilar Monoclonal Antibodies Major Business
Table 40. 3SBIO Biosimilar Monoclonal Antibodies Total Revenue (USD Million) (2018-2019)
Table 41. 3SBIO SWOT Analysis
Table 42. 3SBIO Biosimilar Monoclonal Antibodies Product and Services
Table 43. 3SBIO Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Celgen Biopharma Basic Information, Manufacturing Base and Competitors
Table 45. Celgen Biopharma Biosimilar Monoclonal Antibodies Major Business
Table 46. Celgen Biopharma Biosimilar Monoclonal Antibodies Total Revenue (USD Million) (2018-2019)
Table 47. Celgen Biopharma SWOT Analysis
Table 48. Celgen Biopharma Biosimilar Monoclonal Antibodies Product and Services
Table 49. Celgen Biopharma Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Dr Reddy’s Basic Information, Manufacturing Base and Competitors
Table 51. Dr Reddy’s Biosimilar Monoclonal Antibodies Major Business
Table 52. Dr Reddy’s Biosimilar Monoclonal Antibodies Total Revenue (USD Million) (2018-2019)
Table 53. Dr Reddy’s SWOT Analysis
Table 54. Dr Reddy’s Biosimilar Monoclonal Antibodies Product and Services
Table 55. Dr Reddy’s Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 57. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Major Business
Table 58. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Total Revenue (USD Million) (2018-2019)
Table 59. Torrent Pharmaceuticals SWOT Analysis
Table 60. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Product and Services
Table 61. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Global Biosimilar Monoclonal Antibodies Sales by Manufacturer (2018-2019) (K Units)
Table 63. Global Biosimilar Monoclonal Antibodies Revenue by Manufacturer (2018-2019) (USD Million)
Table 64. Global Biosimilar Monoclonal Antibodies Sales by Regions (2015-2020) (K Units)
Table 65. Global Biosimilar Monoclonal Antibodies Sales Market Share by Regions (2015-2020)
Table 66. Global Biosimilar Monoclonal Antibodies Revenue by Regions (2015-2020) (USD Million)
Table 67. North America Biosimilar Monoclonal Antibodies Sales by Countries (2015-2020) (K Units)
Table 68. North America Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2015-2020)
Table 69. North America Biosimilar Monoclonal Antibodies Revenue by Countries (2015-2020) (USD Million)
Table 70. North America Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2015-2020)
Table 71. Europe Biosimilar Monoclonal Antibodies Sales by Countries (2015-2020) (K Units)
Table 72. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2015-2020)
Table 73. Europe Biosimilar Monoclonal Antibodies Revenue by Countries (2015-2020) (USD Million)
Table 74. Asia-Pacific Biosimilar Monoclonal Antibodies Sales by Regions (2015-2020) (K Units)
Table 75. Asia-Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Regions (2015-2020)
Table 76. Asia-Pacific Biosimilar Monoclonal Antibodies Revenue by Regions (2015-2020) (USD Million)
Table 77. South America Biosimilar Monoclonal Antibodies Sales by Countries (2015-2020) (K Units)
Table 78. South America Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2015-2020)
Table 79. South America Biosimilar Monoclonal Antibodies Revenue by Countries (2015-2020) (USD Million)
Table 80. South America Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2015-2020)
Table 81. Middle East & Africa Biosimilar Monoclonal Antibodies Sales by Countries (2015-2020) (K Units)
Table 82. Middle East & Africa Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2015-2020)
Table 83. Middle East & Africa Biosimilar Monoclonal Antibodies Revenue by Countries (2015-2020) (USD Million)
Table 84. Middle East & Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2015-2020)
Table 85. Global Biosimilar Monoclonal Antibodies Sales by Type (2015-2020) (K Units)
Table 86. Global Biosimilar Monoclonal Antibodies Sales Share by Type (2015-2020)
Table 87. Global Biosimilar Monoclonal Antibodies Revenue by Type (2015-2020) (USD Million)
Table 88. Global Biosimilar Monoclonal Antibodies Revenue Share by Type (2015-2020)
Table 89. Global Biosimilar Monoclonal Antibodies Sales by Application (2015-2020) (K Units)
Table 90. Global Biosimilar Monoclonal Antibodies Sales Share by Application (2015-2020)
Table 91. Global Biosimilar Monoclonal Antibodies Sales Forecast by Regions (2021-2025) (K Units)
Table 92. Global Biosimilar Monoclonal Antibodies Market Share Forecast by Regions (2021-2025)
Table 93. Global Biosimilar Monoclonal Antibodies Sales Forecast by Type (2021-2025) (K Units)
Table 94. Global Biosimilar Monoclonal Antibodies Market Share Forecast by Type (2021-2025)
Table 95. Global Biosimilar Monoclonal Antibodies Sales Forecast by Application (2021-2025)
Table 96. Global Biosimilar Monoclonal Antibodies Market Share Forecast by Application (2021-2025)
Table 97. Direct Channel Pros & Cons
Table 98. Indirect Channel Pros & Cons
Table 99. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Biosimilar Monoclonal Antibodies Picture
Figure 2. Global Sales Market Share of Biosimilar Monoclonal Antibodies by Type in 2019
Figure 3. Infliximab Picture
Figure 4. Rituximab Picture
Figure 5. Trastuzumab Picture
Figure 6. Adalimumab Picture
Figure 7. Other Picture
Figure 8. Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2019
Figure 9. Oncology Picture
Figure 10. Autoimmune Disease Picture
Figure 11. Other Picture
Figure 12. Global Biosimilar Monoclonal Antibodies Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Biosimilar Monoclonal Antibodies Sales Market Share by Manufacturer in 2019
Figure 33. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Biosimilar Monoclonal Antibodies Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Biosimilar Monoclonal Antibodies Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 38. Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Regions (2015-2020)
Figure 40. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Regions in 2018
Figure 41. North America Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
Figure 42. Europe Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
Figure 44. South America Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020)
Figure 46. North America Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2015-2020)
Figure 48. North America Biosimilar Monoclonal Antibodies Sales Market Share by Countries in 2018
Figure 49. North America Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Biosimilar Monoclonal Antibodies Revenue Market Share by Countries in 2018
Figure 51. United States Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Canada Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Mexico Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Europe Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Countries in 2019
Figure 57. Germany Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 58. UK Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 59. France Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Russia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Italy Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Asia-Pacific Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Biosimilar Monoclonal Antibodies Revenue Market Share by Regions 2019
Figure 65. China Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Japan Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Korea Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 68. India Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Southeast Asia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 70. South America Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Biosimilar Monoclonal Antibodies Sales Market Share by Countries in 2019
Figure 72. South America Biosimilar Monoclonal Antibodies Revenue Market Share by Countries in 2019
Figure 73. Brazil Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Argentina Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Middle East and Africa Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Egypt Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Turkey Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 82. South Africa Biosimilar Monoclonal Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Global Biosimilar Monoclonal Antibodies Sales and Growth Rate (2021-2025) (K Units)
Figure 84. Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Biosimilar Monoclonal Antibodies Market Forecast (2021-2025) (K Units)
Figure 86. Europe Sales Biosimilar Monoclonal Antibodies Market Forecast (2021-2025) (K Units)
Figure 87. Asia-Pacific Sales Biosimilar Monoclonal Antibodies Market Forecast (2021-2025) (K Units)
Figure 88. South America Sales Biosimilar Monoclonal Antibodies Market Forecast (2021-2025) (K Units)
Figure 89. Middle East & Africa Sales Biosimilar Monoclonal Antibodies Market Forecast (2021-2025) (K Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
Please feel free to write an email to us or to use our electronic ticketing system.
